Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

7 biggest deal reports this week: $3.6B Phillips 66-DCP Midstream deal

Published 2023-01-08, 04:51 p/m
Updated 2023-01-08, 04:51 p/m
© Reuters.

In one of the biggest deals announced this past week, Phillips 66 agreed to pay $3.8 billion and take an 87% stake in DCP Midstream. Here’s the full list of the most recent head-turning dispatches, as covered first on InvestingPro.

DCP Midstream (NYSE:DCP) gained more than 6% after Phillips 66 (NYSE:PSX) agreed to pay $3.8 billion in cash for all of the publicly held common units representing limited partner interests in DCP, increasing its stake in DCP to 86.8%. Phillips 66 shares gained some 2%.

Western Digital (NASDAQ:WDC) shares gained more than 17% this week following reports from Bloomberg that the company has restarted merger talks with Japan's Kioxia Holdings. While the structure of the deal remains in flux, the parties are said to be discussing merging into one publicly traded company, it was added. The two parties were in talks on a $20 billion merger in 2021 but those talks failed to reach an agreement.

World Wrestling Entertainment (NYSE:WWE) shares surged more than 16% on Friday on the announcement that Vince McMahon, the company's majority owner and former CEO, will be returning to the board and intends to undertake a review of the company’s strategic alternatives, with a goal of maximizing value for all WWE shareholders.

Benchmark analyst Mike Hickey believes that WWE is worth +$105 per share on a potential deal, but noted that there is no assurance that this process will result in a transaction.

Raytheon (NYSE:RTN) Technologies (NYSE:RTX) is considering a sale of a unit that makes products including flight controls, which could fetch about $1 billion, according to Bloomberg, citing people familiar with the matter.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zimmer Biomet Holdings (NYSE:ZBH) announced that it has agreed to buy Embody, Inc., a privately held medical device company focused on soft tissue healing, for $155 million at closing and up to an additional $120 million subject to achieving future regulatory and commercial milestones over a three year period. The transaction is expected to be completed in February 2023.

Moderna (NASDAQ:MRNA) announced they have agreed to acquire OriCiro for $85 million.

Targa Resources (NYSE:TRGP) Corp. agreed to acquire Blackstone (NYSE:BX) Energy Partners’ 25% interest in Targa’s Grand Prix NGL Pipeline (Grand Prix) for $1.05 billion in cash plus customary working capital adjustments. Targa will own 100% of Grand Prix upon closing.

***

If you’re interested in upgrading your search for new investing ideas, check out InvestingPro.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.